FDA Poised To Appeal If Texas District Court Pulls Mifepristone Approval

By Beth Wang / March 21, 2023 at 12:41 PM
FDA is poised to file an appeal if a Texas district court reverses the agency’s more than 20-year-old approval of the abortion pill mifepristone. The agency is doubling down on its request that the judge in the case, Matthew Kacsmaryk, stay any potential adverse ruling for at least 21 days to allow the U.S. government time to seek an “emergency, expedited stay from the court of appeals.” A decision in the high-stakes abortion case could come any day now in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.